Skip to main content

Together we are beating cancer

Donate now

Cancer News

Latest News

Showing 12 out of 6209 results
Michelle Mitchell

Michelle Mitchell OBE, Cancer Research UK’s new CEO, begins her leadership of the charity today, 12 November 2018. Michelle Mitchell OBE, Cancer Research UK’s new CEO, begins her leadership of the charity today, 12 November 2018.

by Cancer Research UK | News | 12 November 2018

12 November 2018

An image of an MRI scan of a brain with the glioblastoma tumour in white.

Our scientists have shown it’s possible to detect brain tumour DNA in the liquid surrounding the brain using a cheap technique. Our scientists have shown it’s possible to detect brain tumour DNA in the liquid surrounding the brain using a cheap technique.

by Gabriella Beer | Analysis | 6 November 2018

6 November 2018

Scientists are making strides in developing liquid biopsies for brain tumours by detecting tumour DNA in the fluid from around the brain and spine. Scientists are making strides in developing liquid biopsies for brain tumours by detecting tumour DNA in the fluid from around the brain and spine.

by Cancer Research UK | News | 6 November 2018

6 November 2018

In the news this week: using Turing’s codebreaking to develop personalised cancer treatments and misleading headlines linking mobile phones to cancer. In the news this week: using Turing’s codebreaking to develop personalised cancer treatments and misleading headlines linking mobile phones to cancer.

by Lily Almeida | Analysis | 3 November 2018

3 November 2018

Mobile phone

US researchers have released a report linking high doses of the radiation given off by mobile phones to increased risk of heart tumours in male rats. US researchers have released a report linking high doses of the radiation given off by mobile phones to increased risk of heart tumours in male rats.

by Weilin Wu | Analysis | 2 November 2018

2 November 2018

This entry is part 23 of 30 in the series Science Snaps
%postcontent%

A drug could help slow the progression of some advanced ovarian cancers and extend the time that patients show no signs of disease, according to new research. A drug could help slow the progression of some advanced ovarian cancers and extend the time that patients show no signs of disease, according to new research.

by In collaboration with PA Media Group | News | 24 October 2018

24 October 2018